Testosterone Cipla 1000 mg Solution for injection
PDF Leaflet Revision Date: October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Testosterone replacement therapy in male hypogonadism.
Dosage (summary)
1000 mg every 10 to 14 weeks; may start at 6 weeks for loading dose.
Onset of Action / Duration
Onset: 1 day, Duration: 10-14 weeks
Special Populations
- Elderly patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not indicated for use in women, including pregnant or breastfeeding women.
Key Drug Interactions
- Increased activity of oral anticoagulants
- Enhanced oedema with corticosteroids
- May affect insulin dosage
Contraindications
- Hypersensitivity to testosterone
- Androgen-dependent carcinoma
- Hypercalcaemia
- Liver tumours
Common side effects
- Acne
- Injection site pain
- Polycythaemia
Counselling Points
- Inject intramuscularly and slowly
- Monitor testosterone levels
- Report any severe side effects
Serious warnings
- Risk of prostatic hyperplasia
- Potential for thrombotic events
- Monitor for polycythaemia
Important Disclaimer
The Testosterone Cipla 1000 mg Solution for injection professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
